Table 1 Participant characteristics of qualitative sample
Qualitative study participants (n = 29) | |
|---|---|
Demographics | |
Mean age in years (SD) | 43.1 (9.8) |
Gender | |
Male | 23 (79%) |
Female | 6 (21%) |
Transgender | 0 (0%) |
Ethnicity | |
Hispanic | 18 (62%) |
Not Hispanic | 11 (38%) |
Race | |
Black | 4 (14%) |
White | 6 (21%) |
Multi-racial | 19 (65%) |
Other groups or refused | 0 |
Birthplace | |
United States | 19 (65%) |
Puerto Rico | 8 (28%) |
Other | 2 (7%) |
Socioeconomic factors | |
Homeless in past 3 months | 16 (55%) |
Ever incarcerated | 26 (90%) |
Employment | |
Unemployed | 25 (86%) |
Disability | 3 (10%) |
“Off-books” employment | 1 (3%) |
Healthcare engagement before study | |
Aware of HCV diagnosis | 25 (86%) |
Referred for HCV treatment | 17 (59%) |
Ever taken HCV treatment | 6 (21%) |
Seen a doctor in the past 3 months | 21 (72%) |
Drug treatment in past 3 months (overall)* | 26 (90%) |
Methadone | 20 (69%) |
Buprenorphine | 1 (3%) |
Residential treatment | 10 (34%) |
Study outcomes | |
Initiated treatment | 29 (100%) |
Completed treatment | 27 (93%) |
Achieved SVR12** | 27 (93%) |